Researchers sought to determine whether enasidenib combined with azacitidine may increase survival in patients with IDH2-mutated myelodysplastic syndrome.
Researchers sought to determine what is the best method for detecting liver iron abundance in patients with MDS.
Researchers sought to determine whether an HSP90 inhibitor and a plant-derived coumarin would have antitumor effects in patients with MDS.
Researchers sought to determine what factors may help predict what patients with MDS or AML would respond to treatment with azacitidine.
Researchers sought to determine whether quizartinib-based combination therapies would be safe and effective treatment options for patients with AML.
Researchers evaluated the rates and significance of HFE variants in a population of patients with MDS.
Researchers sought to determine whether whole-genome sequencing may be a better risk stratification tool compared with conventional cytogenetic analysis.
Researchers sought to determine whether paroxysmal nocturnal hemoglobinuria clones might predict treatment responses for patients with MDS and aplastic anemia.
Hispanic patients with blood cancer who live near the US-Mexico border have worse prognosis despite younger age at diagnosis for blood cancers.
Researchers assessed if older patients with high-risk myelodysplastic syndrome experience significant overall survival benefit from hematopoietic transplantation.
